← Evidence map

ArticleTherapeutics and clinical risk management2019

Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis.

Hans-Klaus GoischkePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31371976